Perspective Therapeutics, Inc. SEC filings CATX
Perspective Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Aug 16, 2006. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Other events
|
Oct 8, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Other events
|
Oct 1, 2026 | Oct 1, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 23, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Aug 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 4, 2026 | — |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 10, 2026 | Aug 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 20, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 30, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Other events
|
May 22, 2026 | May 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 4, 2026 | May 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 20, 2026 | Apr 18, 2026 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Other events
|
Apr 1, 2026 | Apr 1, 2026 |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 16, 2026 | Mar 16, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 10, 2026 | — |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 3, 2026 | Feb 2, 2026 |
| 424B5 | Prospectus supplement | Feb 3, 2026 | — |
| FWP | Free writing prospectus | Feb 2, 2026 | — |
| 8-K |
Current report
Results of operations, Other events
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Other events
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 5, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 1, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 20, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Other events
|
Oct 1, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| 3 | Initial insider ownership | Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 3 | Initial insider ownership | Sep 5, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 4, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 3, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Other events
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Other events
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Other events
|
Jun 23, 2025 | Jun 21, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Other events
|
May 30, 2025 | May 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2025 | May 28, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 19, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Other events
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Other events
|
Apr 29, 2025 | Apr 29, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Apr 11, 2025 | Apr 11, 2025 |
| EFFECT | Filing | Apr 8, 2025 | — |
| POS AM | Filing | Apr 4, 2025 | — |
| 4 | Insider transaction | Apr 1, 2025 | Mar 28, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 28, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 28, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 10-K/A | Amended annual report | Mar 28, 2025 | Dec 31, 2024 |
| S-8 | Employee stock plan registration | Mar 26, 2025 | — |
| POS AM | Filing | Mar 26, 2025 | — |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 26, 2025 | Mar 26, 2025 |
| POSASR | Filing | Mar 26, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 17, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Other events
|
Mar 4, 2025 | Mar 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Other events
|
Jan 24, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 6, 2025 |
| 3 | Initial insider ownership | Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 4, 2024 |
| 4/A | Filing | Dec 4, 2024 | Nov 25, 2024 |
| 4/A | Filing | Dec 4, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Other events
|
Dec 4, 2024 | Dec 3, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Other events
|
Nov 21, 2024 | Nov 21, 2024 |
| 8-K |
Current report
Other events
|
Nov 15, 2024 | Nov 15, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 11, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Sep 20, 2024 | Sep 18, 2024 |
| 144 | Notice of proposed sale | Sep 12, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 5, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2024 | Aug 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2024 | Aug 16, 2024 |
| S-8 | Employee stock plan registration | Aug 14, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Aug 13, 2024 | Aug 13, 2024 |
| 424B5 | Prospectus supplement | Aug 13, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Aug 13, 2024 | Aug 12, 2024 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 14, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 13, 2024 |
| 4/A | Filing | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 31, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 31, 2024 | May 31, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 29, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 29, 2024 | May 24, 2024 |
| 424B5 | Prospectus supplement | May 24, 2024 | — |
| FWP | Free writing prospectus | May 24, 2024 | — |
| S-3ASR | Automatic shelf registration | May 24, 2024 | — |
| 8-K |
Current report
Other events
|
May 20, 2024 | May 20, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 16, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 4 | Insider transaction | Apr 24, 2024 | Apr 23, 2024 |
| SC 13G | Ownership over 5% (passive) | Apr 19, 2024 | — |
| DEFA14A | Additional proxy material | Apr 18, 2024 | — |
| DEF 14A | Proxy statement | Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Acquisition or sale of assets
|
Apr 16, 2024 | Apr 12, 2024 |
| EFFECT | Filing | Apr 9, 2024 | — |
| 424B3 | Prospectus | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 8, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 8, 2024 | May 31, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 8, 2024 | Apr 5, 2024 |
| UPLOAD | Letter from the SEC | Apr 8, 2024 | — |
| 8-K |
Current report
Material agreement
|
Apr 3, 2024 | Mar 28, 2024 |
| S-8 | Employee stock plan registration | Apr 1, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Other events
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Other events
|
Mar 19, 2024 | Mar 18, 2024 |
| D | Filing | Mar 18, 2024 | — |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 8, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 8, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 6, 2024 | Mar 4, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CATX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 728387
- Former names
- IsoRay, Inc. (until Feb 16, 2023); Isoray, Inc. (until Feb 16, 2023); CENTURY PARK PICTURES CORP (until Aug 3, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.